David Kägi

9.6k total citations · 4 hit papers
37 papers, 8.2k citations indexed

About

David Kägi is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, David Kägi has authored 37 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in David Kägi's work include Immune Cell Function and Interaction (20 papers), T-cell and B-cell Immunology (15 papers) and Immune Response and Inflammation (8 papers). David Kägi is often cited by papers focused on Immune Cell Function and Interaction (20 papers), T-cell and B-cell Immunology (15 papers) and Immune Response and Inflammation (8 papers). David Kägi collaborates with scholars based in Switzerland, Canada and United States. David Kägi's co-authors include Hans Hengartner, Kurt Bürki, Birgit Ledermann, Rolf M. Zinkernagel, Bernhard Odermatt, Peter Seiler, Eckhard R. Podack, Valérie Depraetere, Shigekazu Nagata and Françoise Vignaux and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

David Kägi

37 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice

1994 1.5k citations David Kägi, Birgit Ledermann et al. Nature profile →
Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated Cytotoxicity

1994 1.4k citations David Kägi, Birgit Ledermann et al. profile →
Differential Requirement for Caspase 9 in Apoptotic Pathways In Vivo

1998 1.1k citations Razqallah Hakem, Anne Hakem et al. Cell profile →
Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes

1998 747 citations Minna Woo, Razqallah Hakem et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Kägi Switzerland	28	4.8k	3.0k	1.3k	1.3k	725	37	8.2k
Daniela Novick Israel	45	3.9k 0.8×	3.4k 1.2×	1.4k 1.1×	1.3k 1.0×	684 0.9×	90	7.9k
Thomas J. Waldschmidt United States	46	7.3k 1.5×	2.5k 0.9×	989 0.8×	1.3k 1.0×	672 0.9×	113	10.7k
Shin‐ichiro Kashiwamura Japan	28	4.6k 1.0×	2.4k 0.8×	1.6k 1.3×	828 0.6×	445 0.6×	56	7.7k
Holly Cherwinski United States	29	6.4k 1.3×	2.5k 0.9×	1.6k 1.3×	1.3k 1.0×	495 0.7×	36	11.1k
Jean‐Yves Bonnefoy France	54	6.1k 1.3×	2.3k 0.8×	1.3k 1.0×	1.3k 1.0×	505 0.7×	152	10.5k
Paul Conlon United States	48	5.3k 1.1×	3.0k 1.0×	1.3k 1.0×	629 0.5×	883 1.2×	97	9.3k
R. Chris Bleackley Canada	43	3.2k 0.7×	3.3k 1.1×	1.1k 0.8×	1.4k 1.1×	770 1.1×	97	7.0k
Carol Clayberger United States	52	7.4k 1.5×	2.0k 0.7×	1.4k 1.1×	1.3k 1.0×	610 0.8×	156	10.7k
Mariapia A. Degli‐Esposti Australia	48	6.3k 1.3×	2.6k 0.9×	1.3k 1.0×	1.9k 1.4×	617 0.9×	116	9.1k
Toshiaki Ohteki Japan	49	6.5k 1.4×	2.1k 0.7×	1.3k 1.0×	790 0.6×	569 0.8×	115	8.8k

Countries citing papers authored by David Kägi

Since Specialization

Citations

This map shows the geographic impact of David Kägi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Kägi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Kägi more than expected).

Fields of papers citing papers by David Kägi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Kägi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Kägi. The network helps show where David Kägi may publish in the future.

Co-authorship network of co-authors of David Kägi

This figure shows the co-authorship network connecting the top 25 collaborators of David Kägi. A scholar is included among the top collaborators of David Kägi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Kägi. David Kägi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Corazza, Nadia, Stefan Müller, Thomas Brunner, David Kägi, & Christoph Mueller. (2000). Differential Contribution of Fas- and Perforin-Mediated Mechanisms to the Cell-Mediated Cytotoxic Activity of Naive and In Vivo-Primed Intestinal Intraepithelial Lymphocytes. The Journal of Immunology. 164(1). 398–403. 30 indexed citations

Kägi, David, Bernhard Odermatt, & Tak W. Mak. (1999). Homeostatic regulation of CD8+ T cells by perforin. European Journal of Immunology. 29(10). 3262–3272. 124 indexed citations

Kägi, David, Alexandra Ho, Bernhard Odermatt, et al.. (1999). TNF Receptor 1-Dependent β Cell Toxicity as an Effector Pathway in Autoimmune Diabetes. The Journal of Immunology. 162(8). 4598–4605. 77 indexed citations

Broek, Maries van den, David Kägi, & Hans Hengartner. (1998). Effector Pathways of Natural Killer Cells. Current topics in microbiology and immunology. 230. 123–131. 5 indexed citations

Hakem, Razqallah, Anne Hakem, Gordon S. Duncan, et al.. (1998). Differential Requirement for Caspase 9 in Apoptotic Pathways In Vivo. Cell. 94(3). 339–352. 1103 indexed citations breakdown →

Li, L, Subash Sad, David Kägi, & Tim R. Mosmann. (1997). CD8Tc1 and Tc2 cells secrete distinct cytokine patterns in vitro and in vivo but induce similar inflammatory reactions. The Journal of Immunology. 158(9). 4152–4161. 94 indexed citations

Bachmann, Martin F., Toshiaki Ohteki, Arsen Zakarian, et al.. (1997). Altered peptide ligands trigger perforin- rather than Fas-dependent cell lysis. The Journal of Immunology. 159(9). 4165–4170. 16 indexed citations

Duncan, G S, Hans-Willi Mittrücker, David Kägi, T. Matsuyama, & Tak W. Mak. (1996). The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo.. The Journal of Experimental Medicine. 184(5). 2043–2048. 106 indexed citations

Kägi, David & Hans Hengartner. (1996). Different roles for rcytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Current Opinion in Immunology. 8(4). 472–477. 154 indexed citations

10.

Sad, Subash, David Kägi, & Tim R. Mosmann. (1996). Perforin and Fas killing by CD8+ T cells limits their cytokine synthesis and proliferation.. The Journal of Experimental Medicine. 184(4). 1543–1547. 74 indexed citations

11.

Kägi, David, Bernhard Odermatt, Pamela S. Ohashi, Rolf M. Zinkernagel, & Hans Hengartner. (1996). Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity.. The Journal of Experimental Medicine. 183(5). 2143–2152. 102 indexed citations

12.

Stallmach, Thomas, et al.. (1995). The role of perforin‐expression by granular metrial gland cells in pregnancy. European Journal of Immunology. 25(12). 3342–3348. 27 indexed citations

13.

Kägi, David, Peter Seiler, Jovan Pavlovic, et al.. (1995). The roles of perforin‐ and Fas‐dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. European Journal of Immunology. 25(12). 3256–3262. 243 indexed citations

14.

Kägi, David, et al.. (1995). Lymphocyte‐mediated Cytotoxicity in vitro and in vivo: Mechanisms and Significance. Immunological Reviews. 146(1). 95–115. 82 indexed citations

15.

Schulz, Manfred, Henk‐Jan Schuurman, Joanne Joergensen, et al.. (1995). Acute rejection of vascular heart allografts by perforin‐deficient mice. European Journal of Immunology. 25(2). 474–480. 83 indexed citations

16.

Broek, Maries van den, David Kägi, R M Zinkernagel, & Hans Hengartner. (1995). Perforin dependence of natural killer cell‐mediated tumor control in vivo. European Journal of Immunology. 25(12). 3514–3516. 143 indexed citations

17.

Kägi, David, Birgit Ledermann, Kurt Bürki, Hans Hengartner, & Rolf M. Zinkernagel. (1994). CD8⁺ T cell‐mediated protection against an intracellular bacterium by perforin‐dependent cytotoxicity. European Journal of Immunology. 24(12). 3068–3072. 191 indexed citations

18.

Kägi, David, Birgit Ledermann, Kurt Bürki, et al.. (1994). Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 369(6475). 31–37. 1504 indexed citations breakdown →

19.

Müller, Christoph, David Kägi, Toni Aebischer, et al.. (1989). Detection of perforin and granzyme A mRNA in infiltrating cells during infection of mice with lymphocytic choriomeningitis virus. European Journal of Immunology. 19(7). 1253–1259. 70 indexed citations

20.

Müller, Marcel, David Kägi, & A. Fürst. (1981). Epimerization at a quaternary C-substituted carbon atom. Tetrahedron. 37. 257–261. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact